Frontlight ResearchEarly access
Type 1 diabetes trials in United Kingdom
15 of 33 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseCompletedReal-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- Where
- Birmingham, London
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07457580 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Edinburgh, London
- Age
- 18 years to 99 years
- People
- 24,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - No phaseTaking peopleBenefits of Retained Insulin for Good Health
- Where
- Bath, Bristol, Exeter, Truro
- Age
- 18 years and over
- People
- 700
- Run by
- Royal Devon and Exeter NHS Foundation Trust
See details and how to joinNCT07828626 - No phaseNot yet taking people in United KingdomImplementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)
- Where
- London
- Age
- 18 years and over
- People
- 70
- Run by
- Imperial College Healthcare NHS Trust
See details and how to joinNCT07769138 - No phaseNot yet taking people in United KingdomDiathermy On Diabetes Glucose Monitoring Effectiveness
- Where
- Nottingham
- Age
- 4 years and over
- People
- 126
- Run by
- University of Nottingham
See details and how to joinNCT07583238 - No phaseTaking peopleCapillary OGTT Study
- Where
- Cardiff, London, Nottingham, Oxford
- Age
- Up to 17 years
- People
- 135
- Run by
- University of Oxford
See details and how to joinNCT06815081 - No phaseTaking peopleCONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
- Where
- Edinburgh, Glasgow, Ipswich, Leeds, Southampton
- Age
- 6 years and over
- People
- 225 worldwide
- Run by
- University of Manitoba
See details and how to joinNCT05754567 - No phaseTaking peopleThe Seafarers' Continuous Glucose Monitoring Systems Study
- Where
- Guildford
- Age
- 18 years and over
- People
- 50
- Run by
- University of Surrey
See details and how to joinNCT07251257 - No phaseTaking peopleEXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Where
- Exeter, London
- Age
- Up to 70 years
- People
- 300 worldwide
- Run by
- University of Exeter
See details and how to joinNCT03369821 - No phaseTaking peopleUK Islet Autoantibody Registry
- Where
- Oxford
- Age
- 6 months to 70 years
- People
- 350
- Run by
- University of Oxford
See details and how to joinNCT07125365 - No phaseSuspendedTrialNet Pathway to Prevention of T1D
- Where
- Bristol
- Age
- 2 years to 45 years
- People
- 75,000 worldwide
- Run by
- University of South Florida
See details and how to joinNCT00097292 - No phaseEnrolling by invitationAssessing Remote Confirmation of Type 1 Diabetes
- Where
- Exeter
- Age
- 18 years and over
- People
- 1,000
- Run by
- Royal Devon and Exeter NHS Foundation Trust
See details and how to joinNCT06821360 - No phaseTaking peopleChronotype of Patients With Diabetes and Effect on Glycaemic Control
- Where
- Leicester
- Age
- 18 years to 75 years
- People
- 3,447
- Run by
- University of Leicester
See details and how to joinNCT02973412 - No phaseTaking peopleNational Registry of Rare Kidney Diseases
- Where
- Bristol
- People
- 35,000
- Run by
- UK Kidney Association
See details and how to joinNCT06065852 - No phaseTaking peopleParaoxonase and HDL Qualities in Glycaemia and Inflammation
- Where
- Manchester
- Age
- 20 years to 75 years
- People
- 600
- Run by
- Manchester University NHS Foundation Trust
See details and how to joinNCT02169518